New—Roux-en-Y gastric bypass, adjustable gastric banding, or sleeve gastrectomy for severe obesity (By-Band-Sleeve): a multicentre, open label, three-group, randomised controlled trial https://t.co/X6OYafdYkY
#BariatricSurgery#obesity#OpenAccess
Access to obesity services is severely restricted across England.
Over 1/3 of areas have restricted or no access to tier 3 services, while 1/5 have no bariatric surgery service.
My investigation for @bmj_latest👇
@bariatricBOMSS@NHeslehurst@UK_ASO https://t.co/kqOndxf6QA
UK doctors are calling for a national public awareness campaign to inform people of the risks of going overseas for weight loss surgery. Ahmed Ahmed, BOMSS Secretary, has spoken with @bmj_latest on this important issue - https://t.co/AXTMglwiv4
How effective is bariatric surgery compared with medical/lifestyle management for long-term control of type 2 diabetes?
Watch this and learn the answer: https://t.co/ySGZW7Os5K
@MarkCheetham Agreed. The move from central NHSE to local commissioning no doubt contributes to the variation. A small study we did in this area: https://t.co/xWLJuidkDG
@MarkCheetham Very true - both prevention and treatment are key like all long term conditions. Some good studies in this area: https://t.co/P2XN4cdomQ https://t.co/6MTwUTUBYi
@OMGhanemMD Nice paper - makes a strong argument against RYGB as a therapy of last resort - but how to make it a more visible choice for people living with T2 diabetes and obesity who are in primary care or in diabetes clinics? @parthaskar@kamleshkhunti
📢📢📢
We are glad to introduce the 8th IFSO Global Registry Report 2023
> 480,970 Metabolic and Bariatric Surgeries (MBS)
> 24 countries
> 2 regional registries representing
> 81.4% of known registries
Check it out here:
https://t.co/qHzQcgJgVK
Life expectancy after bariatric surgery or usual care in patients with or without baseline type 2 diabetes in Swedish Obese Subjects https://t.co/VEtamK2m5X